Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126896031 | 12689603 | 1 | I | 20150930 | 0 | 20160825 | 20160825 | DIR | 78.00 | YR | M | N | 0.00000 | 20160819 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126896031 | 12689603 | 1 | PS | OFLOXACIN OTIC | OFLOXACIN | 1 | 4 DROPS 2X/DAY FOR 14 DAYS DROPS IN OPEN EARDRUM | N | D | 214511 | 201705 | 0 | 4 | GTT | BID | ||||
| 126896031 | 12689603 | 2 | SS | CIPRODEX | CIPROFLOXACIN HYDROCHLORIDEDEXAMETHASONE | 1 | 4-5 DROPS INTO EAR X DAY 10 DAYS (QUIT AFTER 1 DAY-STEROID | 201610 | 0 | ||||||||||
| 126896031 | 12689603 | 3 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 4 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 6 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 8 | C | GUMMY VITS | 2 | 0 | |||||||||||||
| 126896031 | 12689603 | 10 | C | PROBIOTIC | PROBIOTICS NOS | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 13 | C | COQ10 | UBIDECARENONE | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 15 | C | N-AC | 2 | 0 | |||||||||||||
| 126896031 | 12689603 | 17 | C | C | 2 | 0 | |||||||||||||
| 126896031 | 12689603 | 19 | C | LIQUID B'S | 2 | 0 | |||||||||||||
| 126896031 | 12689603 | 21 | C | KRILL OIL | DIETARY SUPPLEMENT | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 23 | C | OTHER GOOD OILS | 2 | 0 | |||||||||||||
| 126896031 | 12689603 | 25 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 27 | C | NAPROXEN SODIUM. | NAPROXEN SODIUM | 1 | 0 | ||||||||||||
| 126896031 | 12689603 | 31 | C | XCLEAR SINUS SPRAY | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126896031 | 12689603 | 1 | Myringitis |
| 126896031 | 12689603 | 1 | Tympanic membrane perforation |
| 126896031 | 12689603 | 2 | Neuropathy peripheral |
| 126896031 | 12689603 | 2 | Tendon rupture |
| 126896031 | 12689603 | 2 | Tinnitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126896031 | 12689603 | DS |
| 126896031 | 12689603 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126896031 | 12689603 | Condition aggravated | |
| 126896031 | 12689603 | Hypoglycaemia | |
| 126896031 | 12689603 | Neuropathy peripheral | |
| 126896031 | 12689603 | Overdose | |
| 126896031 | 12689603 | Tendon rupture | |
| 126896031 | 12689603 | Tendonitis | |
| 126896031 | 12689603 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126896031 | 12689603 | 1 | 20150918 | 20151002 | 14 | DAY |